Aytu BioPharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.09 M | $2.04 M | 0.00% | 17.31% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 891.86 K | $1.68 M | 9.74% | 14.20% |
| AWM INVESTMENT COMPANY, INC. | 11/13/2025 | 619.57 K | $1.16 M | -0.05% | 9.87% |
| VANGUARD GROUP INC | 11/07/2025 | 278.58 K | $523.74 K | 898.94% | 4.44% |
| DIADEMA PARTNERS LP | 11/14/2025 | 272.67 K | $512.62 K | 100.00% | 4.34% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 95.12 K | $178.83 K | 5.79% | 1.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 71.01 K | $133.52 K | 31.81% | 1.13% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 68.74 K | $129.22 K | 96.19% | 1.09% |
| PERSISTENT ASSET PARTNERS LTD | 11/10/2025 | 62.45 K | $117.41 K | 100.00% | 0.99% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 39.80 K | $74.82 K | 100.00% | 0.63% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 30.96 K | $58.21 K | 100.00% | 0.49% |
| BLACKROCK, INC. | 11/12/2025 | 22.79 K | $42.85 K | 0.00% | 0.36% |
| JAFFETILCHIN INVESTMENT PARTNERS, LLC | 11/13/2025 | 17.44 K | $32.78 K | 0.00% | 0.28% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 10.24 K | $19.00 K | 0.00% | 0.16% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 4.32 K | $8.13 K | 70.33% | 0.07% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 3.58 K | $6.72 K | 0.00% | 0.06% |
| UBS GROUP AG | 11/13/2025 | 3.14 K | $5.90 K | 2.89% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 455 | $803 | 51.67% | 0.01% |
| MORGAN STANLEY | 11/14/2025 | 286 | $538 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 127 | $239 | 0.00% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/24/2025 | 83 | $156 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 74 | $139 | 17.46% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 62 | $117 | -70.62% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 37 | $70 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 23 | $43 | 0.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 21 | $39 | 0.00% | 0.00% |
| FMR LLC | 11/13/2025 | 5 | $9 | 100.00% | 0.00% |
| VISION FINANCIAL MARKETS LLC | 11/06/2025 | 2 | $4 | 0.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 1 | $2 | 100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 1 | $2 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 1 | $2 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| KANEN WEALTH MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aytu BioPharma, Inc. institutional Ownership - FAQ's
During the previous two years, 38 institutional investors and hedge funds held shares of Aytu BioPharma, Inc.. The most heavily invested institutionals were:
Nantahala Capital Management, LLC: 1.09 M
Stonepine Capital Management, LLC: 891,855
AWM Investment Company, Inc.: 619,574
VANGUARD GROUP INC: 278,583
DIADEMA PARTNERS LP: 272,670
RENAISSANCE TECHNOLOGIES LLC: 95,123
57.01% of Aytu BioPharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.64 M shares in the last 24 months. This purchase volume represents approximately $8.15 M in transactions.